England and Wales
|
001-39992
|
Not Applicable
|
(State or other jurisdiction of incorporation)
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
92 Park Drive,
Milton Park
Abingdon, Oxfordshire,
United Kingdom
|
OX14 4RY
|
|
(Address of principal executive offices)
|
(Zip Code)
|
☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Title of each class
|
Trading
Symbol(s)
|
Name of each exchange on which registered
|
American Depositary Shares, each representing one ordinary share, nominal value £0.002 per share
|
IMCR
|
The Nasdaq Stock Market LLC
|
Ordinary share, nominal value £0.002 per share*
|
*
|
The Nasdaq Stock Market LLC
|
Item 7.01.
|
Regulation FD Disclosure.
|
IMMUNOCORE HOLDINGS PLC
|
||||
Dated: January 2, 2024
|
By:
|
/s/ Bahija Jallal, Ph.D.
|
||
Name:
|
Bahija Jallal, Ph.D.
|
|||
Title:
|
Chief Executive Officer
|